MYOCARDIAL VIABILITY--NUCLEAR TECHNIQUES
MYOCARDIAL VIABILITY--NUCLEAR TECHNIQUES
批准号:
2576840
负责人:
V DILSIZIAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
angiography cardiac output cardiovascular stress test clinical research coronary disorder heart circulation heart dimension /size heart disorder diagnosis heart function heart revascularization human subject magnetic resonance imaging myocardial infarct sizing myocardial ischemia /hypoxia positron emission tomography prognosis radiodiagnosis thallium
中文摘要
可逆(缺血性)和轻中度不可逆(非缺血性)
铊缺陷代表具有存活心肌的区域。 以来
仅仅存在存活心肌并不一定表明缺血
心肌,我们研究了应激诱导的可逆铊
缺陷在预测功能恢复方面更准确,
与非缺血但存活心肌相比的血运重建
(轻度-中度不可逆铊缺陷)。 我们研究了11名患者
患有慢性冠状动脉疾病的患者,
血运重建后定量应力再分布再注射
门控磁共振成像(MRI)和放射性核素
动脉造影 静息时平均LV射血分数从31
血运重建前± 8%至38 ± 11%
血运重建后(P <0.05)。 两到四次核磁共振和轴向铊
对每个患者的切片进行匹配和分析。 对于每个切片,
对血管重建后收缩期室壁增厚进行了目视评估,
MRI的5个区域。 在总共137个血运重建区域中,62个区域
血管重建前室壁运动异常,其中42例改善
20例无改善。 在42例异常中,
血管重建后改善的区域,21个(50%)显示
可逆性铊缺陷,仅2例轻度-中度不可逆性
缺陷 相比之下,在20个没有改善的异常区域中,
血运重建后,14例(70%)显示轻中度不可逆性
只有3例具有可逆性铊缺陷(p <0.0001)。 这些
数据表明,在进行压力研究时,大多数轻度-中度压力
不可逆的铊区域代表了一种混合物,
(非缺血性)和瘢痕心肌可能不会改善
再血管化后。 另一方面,
在失能区中的应力上的可逆铊缺陷更多
准确预测血运重建后的功能恢复。
英文摘要
Reversible (ischemic) and mild-moderate irreversible (nonischemic)
thallium defects represent regions with viable myocardium. Since the
mere presence of viable myocardium does not necessarily indicate ischemic
myocardium, we investigated whether stress-induced reversible thallium
defects are more accurate in predicting recovery of function after
revascularization compared to nonischemic but viable myocardium
(mild-moderate irreversible thallium defects). We studied 11 patients
with chronic coronary artery disease who underwent pre- and
post-revascularization quantitative stress-redistribution-reinjection
thallium, gated magnetic resonance imaging (MRI) and radionuclide
angiography. Mean LV ejection fraction at rest increased from 31
plus/minus 8% pre-revascularization to 38 plus/minus 11%
post-revascularization (p<0.05). Two to four MRI and thallium transaxial
slices were matched and analyzed per patient. For each slice, pre- and
post-revascularization systolic wall thickening was visually assessed in
5 regions by MRI. From a total of 137 revascularized regions, 62 regions
had abnormal wall motion pre-revascularization, of which 42 improved
post-revascularization and 20 did not improve. Among the 42 abnormal
regions which improved post-revascularization, 21 (50%) exhibited
reversible thallium defects and only 2 had mild-moderate irreversible
defects. In contrast, of the 20 abnormal regions that did not improve
post-revascularization, 14 (70%) demonstrated mild-moderate irreversible
defects and only 3 had reversible thallium defects (p<0.0001). These
data suggest that when performing stress studies, most mild-moderate
irreversible thallium regions represent an admixture of viable
(nonischemic) and scarred myocardium that may not improve
post-revascularization. On the other hand, the identification of
reversible thallium defect on stress in an asynergic region more
accurately predicts recovery of function after revascularization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOMOGRAPHIC RADIONUCLIDE ANGIOGRAPHY
-
批准号:5203588
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
IDENTIFICATION OF VIABLE MYOCARDIUM IN LEFT VENTRICULAR DYSFUNCTION
-
批准号:3757707
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
IDENTIFICATION OF VIABLE MYOCARDIUM IN LEFT VENTRICULAR DYSFUNCTION
-
批准号:3779626
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
ASSESSMENT OF MYOCARDIAL VIABILITY WITH TECHNETIUM-99M SESTAMIBI
-
批准号:3843415
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
COMPARISON OF SESTAMIBI DEFECTS WITH KNOWN INDICES OF ADVERSE PROGNOSIS
-
批准号:3757717
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
CONGESTIVE HEART FAILURE--NUCLEAR STUDIES
-
批准号:6162743
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL VIABILITY--NUCLEAR TECHNIQUES
-
批准号:5203580
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
HISTOMORPHOLOGIC CORRELATION OF NUCLEAR STUDIES
-
批准号:5203585
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
HISTOMORPHOLOGIC VALIDATION OF THALLIUM AND 18FDG PET CRITERIA FOR VIABILITY
-
批准号:3757718
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
ASSESSMENT OF MYOCARDIAL VIABILITY BY THALLIUM SCINTIGRAPHY
-
批准号:3858129
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL VIABILITY--NUCLEAR TECHNIQUES
-
批准号:6162742
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL VIABILITY--POSITRON EMISSION TOMOGRAPHY
-
批准号:6162768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
PERSISTENT REGIONAL WALL MOTION ABNORMALITIES FOLLOWING EXERCISE
-
批准号:3757710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
POST STRESS LEFT VENTRICULAR CONTRACTILE DYSFUNCTION
-
批准号:6162767
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
CONGESTIVE HEART FAILURE--NUCLEAR STUDIES
-
批准号:2576844
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL BLOOD FLOW CHANGES DURING LOW DOSE DOBUTAMINE/METABOLIC IMAGING
-
批准号:6162766
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
CONGESTIVE HEART FAILURE--NUCLEAR STUDIES
-
批准号:5203589
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
PERSISTENT REGIONAL WALL MOTION ABNORMALITIES FOLLOWING EXERCISE
-
批准号:3779635
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
海外基金